Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 01/18/22 12:00:00 on US and Canada Markets.
Closing in on high-grade areas at Tiria-Shimpia. Based on feedback from Professor Gregor Borg, a specialist in sediment-hosted copper, zinc, and lead, management is gaining a better understanding of the sediment-hosted silver-zinc and copper-silver targets at Tiria-Shimpia and Tsenken, respect...
FY2021 Results. Stem reported net revenue of revenue of $35.8 million compared to $14.0 million last year. Excluding the subsequently divested Driven operations, net revenue totaled $20.9 million, up 49% y-o-y. Adjusted EBITDA loss for the year totaled $5.8 million, compared to a loss of $5.4 ...
Container outlook remains strong. In a webinar hosted by Capital Link, CEO Aristides Pittas and CFO Tasos Aslides highlighted positive macro and micro trends. The macro outlook for the container market looks solid based on firm demand and upcoming emission regulations despite the high order bo...
Exceeds fiscal Q1 expectations. The company's fiscal year started off strongly, with first quarter revenues exceeding our expectations ($14.3 million versus our $12.3 million estimate). First quarter revenues grew 92% year-over-year from $7.5 million in the first quarter of fiscal 2021. Adjust...
>During the fourth quarter, mining companies (as measured by the XME) appreciated 7.3% compared to a gain of 10.6% for the S&P 500 index. The VanEck Vectors Gold Miners (GDX) and Junior Gold Miners (GDXJ) ETFs were up 8.7% and 9.4%, respectively. Gold, silver, copper, and zinc futures p...
>During the fourth quarter, mining companies (as measured by the XME) appreciated 7.3% compared to a gain of 10.6% for the S&P 500 index. The VanEck Vectors Gold Miners (GDX) and Junior Gold Miners (GDXJ) ETFs were up 8.7% and 9.4%, respectively. Gold, silver, copper, and zinc futures p...
Vancouver, British Columbia, January 4, 2022 – Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced that Health Canada has approved a phase 2 clini...
Three Technology Platforms With Innovative Products Imugene is developing novel immunotherapies that fight cancer by using oncoviruses, gene transfer, and antigen delivery. Its three technology platforms are in development to kill cancer cells directly, replace the use of monoclonal antibodies...
Covaxin Shows Efficacy Against Variants Ocugen announced that a new study at Emory University has shown that booster doses of Covaxin, its COVID-19 vaccine, produce effective levels of neutralizing antibodies against both the Omicron and Delta variants. We see this as consistent with previous ...
InPlay set initial 2022 capital budget and operational guidance above our aggressive targets. Management plans to spend C$58 million (vs our C$52) to drill 17 wells (16). With wells paying for themselves in months, expanding drilling is an easy decision. Notably, six of the wells will be drill...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
17.19%Change Percent:
Vivos Company Name:
RDGL Stock Symbol:
OTCMKTS Market:
radiogel.com Website: